A.R.T. Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

A.R.T. Advisors’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-24,931	Closed	-$1.55M	–	1080
2019 Q4	$1.55M	Buy	+24,931	New	+$1.18M	0.08%	392
2018 Q4	–	Sell	-11,671	Closed	-$451K	–	1737
2018 Q3	$451K	Buy	+11,671	New	+$431K	0.02%	899
2018 Q2	–	Sell	-58,576	Closed	-$1.17M	–	1823
2018 Q1	$1.17M	Buy	+58,576	New	+$1.48M	0.05%	590

Other funds holding DCPH

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

A.R.T. Advisors's DCPH Position: Q1 2020 in Review

A.R.T. Advisors sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2020, closing a stake of 24,931 shares — an estimated $1.55M sold.

A.R.T. Advisors first reported a position in DCPH in Q1 2018 and held it in 3 quarters. The position peaked at $1.55M in Q4 2019. 148 funds tracked by Wall St. Rank hold DCPH as of Q1 2020.

A.R.T. Advisors reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
A.R.T. Advisors sold 24,931 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $1.55M.
A.R.T. Advisors first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 3 quarters.
A.R.T. Advisors's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $1.55M in Q4 2019.
148 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.